Ingalls & Snyder LLC Illumina, Inc. Transaction History

Ingalls & Snyder LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$92.79 - $142.53 $1.57 Million - $2.4 Million	16,869 New	16,869 $2.35 Million
Q3 2020 Oct 21, 2020	SELL	$268.51 - $400.74 $156,809 - $234,032	-584 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$256.46 - $373.01 $149,772 - $217,837	584 New	584 $216,000
Q3 2019 Oct 16, 2019	SELL	$266.84 - $378.23 $164,907 - $233,746	-618 Closed	0 $0
Q2 2019 Jul 11, 2019	SELL	$300.59 - $368.15 $30,058 - $36,815	-100 Reduced 13.93%	618 $228,000
Q4 2018 Jan 24, 2019	BUY	$272.46 - $366.54 $18,527 - $24,924	68 Added 10.46%	718 $215,000
Q3 2018 Oct 24, 2018	BUY	$279.04 - $367.06 $181,376 - $238,589	650 New	650 $239,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.